CTRI/2021/01/030660尚未招募1 期
A clinicopathological study on Prameha Purvarupa (Pre-Diabetic Condition) and its management with Nisha-Amalaki Churna and Shilajeet Vati
Esha Dhiman1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2021年1月25日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 30
- 试验地点
- 1
- 主要终点
- To control the symptoms of Prameha Purvarupa
研究概览
简要总结
This is a Clinico- Pathological Study on Prameha Purvarupa i.e Pre- Diabetic condition and its management with Nisha-Amalaki Churna and Shilajeet Vati. This is done compulsory part of Post Graduate Course. Total No. of Patients to be studied is 30 with duration of 30 days.
研究设计
- 研究类型
- Interventional
- 分配方式
- Coin toss, Lottery, toss of dice, shuffling cards etc
- 盲法
- Not Applicable
入排标准
- 年龄范围
- 30.00 Year(s) 至 65.00 Year(s)（—）
- 性别
- All
入选标准
- •Both new and treated cases will be included.
- •Patients who fulfill the diagnostic criteria.
- •Patients age between 30-65 years.
- •Patients having fasting plasma glucose 100- 125 mg%
- •Patients with HbA1c 5.7%-6.4%
- •Patients having symptoms of Prabhuta mutrata (frequency of micturition), pipasa (increased thirst), kshudha (excessive appetite), kara- pada daha (burning sensation in hand and feet), kara-pada suptata (numbness of hand and feet), sweda pravritti (excessive sweating), mukha shosha (dry mouth), mukha madhurya (sweetness in mouth), sheeta priyata (liking for cold things) madhura shukla mutrata (sweetness in urine).
- •Subject willing to follow the procedures as per the study protocol and voluntarily signing informed consent form.
排除标准
- •Patients age <30 years and >65 years .
- •Patients having fasting plasma glucose > 125mg%
- •Patients with HbA1c 6.5% or more.
- •Patients having complications of diabetes like ketoacidosis, nephropathy, neuropathy, retinopathy, and diabetic wounds.
- •Patients having chronic, contagious infection disease such as active tuberculosis, hepatits B or C, or HIV
- •Pregnant and lactating females.
- •Patients having active metabolic or gastrointestinal disease that may interfere with nutrient absorption, metabolism, excretion, excluding diabetes.
- •Type-1 diabetes mellitus and Type-2 diabetes mellitus.
结局指标
主要结局
To control the symptoms of Prameha Purvarupa
时间窗: To control the symptoms of Prameha Purvarupa
次要结局
- Nisha-amalaki churna is more effective than Shilajeet vati individually.(31 days)
研究者
研究点 (1)
Loading locations...
相似试验
尚未招募
1 期
To study the effect of Nisha-Amalaki Churna and Shilajeet Vati in Prameha (Pre-Diabetic)CTRI/2021/01/030660Esha Dhiman
招募中
不适用
Association of warning signs of prameha with signs of prediabetes.CTRI/2022/11/047190Tilak Ayurved Mahavidyalaya200
尚未招募
2 期
An Ayurvedic approach to DiabesityCTRI/2024/05/067387Dr Lipsa Mohapatra
尚未招募
不适用
To study add on effect of Gomutra Triphala Vati with oral Hypoglycemic agent in Prameha(Type II Diabetes Mellitus)CTRI/2023/10/058920PDEAs College Of Ayurved And Research Centre Nigdi pune60
尚未招募
1/2 期
Comparison of nishakatkadi ghan vati with oral hypoglycemic agent in the treatment of diabetes mellitusCTRI/2020/03/024195Principal PDEAs college of Ayurved and Research centre60